Eterna Therapeutics (ERNA) Fails to deliver data

Key failure to deliver metrics for Eterna Therapeutics:

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: £0.69 M
• Last 3 months FTD volume: £2.03 M
• Last year FTD volume: £2.03 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Eterna Therapeutics (ERNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Eterna Therapeutics (ERNA) - since 2022

Eterna Therapeutics (ERNA) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Baxter BAX	£9.52 M	£40.05 M	🇺🇸 USA
Geron GERN	£8.07 M	£27.82 M	🇺🇸 USA
Omeros Corporation OMER	£1.98 M	£7.05 M	🇺🇸 USA
Sanofi SNY	£1.53 M	£65.43 M	🇫🇷 France
Bio-Techne TECH	£1.66 M	£25.45 M	🇺🇸 USA
Genetic Technologies GENE	N/A	£1.12 M	🇦🇺 Australia
Teva Pharmaceutical Industries TEVA	£15.72 M	£40.98 M	🇮🇱 Israel